Literature DB >> 15239661

Studies toward the discovery of the next generation of antidepressants. 3. Dual 5-HT1A and serotonin transporter affinity within a class of N-aryloxyethylindolylalkylamines.

Richard E Mewshaw1, Dahui Zhou, Ping Zhou, Xiaojie Shi, Geoffrey Hornby, Taylor Spangler, Rosemary Scerni, Deborah Smith, Lee E Schechter, Terrance H Andree.   

Abstract

N-aryloxylethylindolealkylamines (5) having dual 5-HT transporter and 5-HT(1A) affinity are described. These compounds represent truncated analogues of our previously reported piperidinyl derivatives (3). Compounds in this investigation were found to have more similar affinities and functional activities for the 5-HT(1A) receptor and 5-HT transporter. Though 5-HT(1A) antagonism is not consistently observed throughout series 5, several molecular features were found to be essential to obtain high and balanced activities. The proper placement of a heteroatom in the aryl ring and the length of the linkage used to tether the indole moiety had significant influence on 5-HT(1A) and 5-HT transporter affinities. Introduction of a halogen into the aryl ring usually lowered intrinsic activity and in some cases led to full 5-HT(1A) antagonists. Compounds 33 and 34 were observed to be full 5-HT(1A) antagonists with K(i) values of approximately 30 nM for the 5-HT(1A) receptor and K(i) values of 5 and 0.5 nM for the 5-HT transporter, respectively. Unfortunately, similar to our previous series (3), compounds in this report also had high affinity for the alpha(1) receptor.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15239661     DOI: 10.1021/jm0304010

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  8 in total

1.  Preclinical characterization of WAY-211612: a dual 5-HT uptake inhibitor and 5-HT (1A) receptor antagonist and potential novel antidepressant.

Authors:  C E Beyer; Q Lin; B Platt; J Malberg; G Hornby; K M Sullivan; D L Smith; T Lock; P J Mitchell; N T Hatzenbuhler; D A Evrard; B L Harrison; R Magolda; M N Pangalos; L E Schechter; S Rosenzweig-Lipson; T H Andree
Journal:  Br J Pharmacol       Date:  2009-03-26       Impact factor: 8.739

2.  A two stage click-based library of protein tyrosine phosphatase inhibitors.

Authors:  Jian Xie; Christopher T Seto
Journal:  Bioorg Med Chem       Date:  2006-10-12       Impact factor: 3.641

3.  Structure-activity relationships of 2,N(6),5'-substituted adenosine derivatives with potent activity at the A2B adenosine receptor.

Authors:  Hayamitsu Adachi; Krishnan K Palaniappan; Andrei A Ivanov; Nathaniel Bergman; Zhan-Guo Gao; Kenneth A Jacobson
Journal:  J Med Chem       Date:  2007-03-23       Impact factor: 7.446

4.  Hit-to-lead optimization of novel benzimidazole phenylacetamides as broad spectrum trypanosomacides.

Authors:  Nicole McNamara; Raphael Rahmani; Melissa L Sykes; Vicky M Avery; Jonathan Baell
Journal:  RSC Med Chem       Date:  2020-05-29

5.  Oxysporizoline, an antibacterial polycyclic quinazoline alkaloid from the marine-mudflat-derived fungus Fusarium oxysporum.

Authors:  Viviane Nenkep; Keumja Yun; Byeng Wha Son
Journal:  J Antibiot (Tokyo)       Date:  2016-01-06       Impact factor: 2.649

Review 6.  Innovative approaches for the development of antidepressant drugs: current and future strategies.

Authors:  Lee E Schechter; Robert H Ring; Chad E Beyer; Zoë A Hughes; Xavier Khawaja; Jessica E Malberg; Sharon Rosenzweig-Lipson
Journal:  NeuroRx       Date:  2005-10

7.  Synthesis and Biological Evaluation of an Indazole-Based Selective Protein Arginine Deiminase 4 (PAD4) Inhibitor.

Authors:  Caroline Chandra Tjin; Rebecca F Wissner; Haya Jamali; Alanna Schepartz; Jonathan A Ellman
Journal:  ACS Med Chem Lett       Date:  2018-09-14       Impact factor: 4.345

8.  Spirotetrahydro beta-carbolines (spiroindolones): a new class of potent and orally efficacious compounds for the treatment of malaria.

Authors:  Bryan K S Yeung; Bin Zou; Matthias Rottmann; Suresh B Lakshminarayana; Shi Hua Ang; Seh Yong Leong; Jocelyn Tan; Josephine Wong; Sonja Keller-Maerki; Christoph Fischli; Anne Goh; Esther K Schmitt; Philipp Krastel; Eric Francotte; Kelli Kuhen; David Plouffe; Kerstin Henson; Trixie Wagner; Elizabeth A Winzeler; Frank Petersen; Reto Brun; Veronique Dartois; Thierry T Diagana; Thomas H Keller
Journal:  J Med Chem       Date:  2010-07-22       Impact factor: 7.446

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.